Adjusted earnings per share of $2.20 missed estimates as U.S. consumers cut spending amid inflation pressures. PepsiCo posted adjusted earnings of $2.20 per share for the second quarter, below the $2.21 analysts expected. Revenue reached $24.18 billion, slightly above the
PepsiCo reports Q2 2026 core earnings per share of $2.20, exceeding estimates of $2.19, with revenue reaching $24.81B. PepsiCo posted Q2 2026 core earnings per share of $2.20, surpassing the estimated $2.19. Revenue climbed to $24.81 billion, above the $23.96 billion forec
PepsiCo reports $2.20 non-GAAP EPS missing expectations by $0.01 while revenue of $24.18B exceeds forecasts by $230M. PepsiCo posted second-quarter non-GAAP earnings per share of $2.20, missing estimates by $0.01. Revenue reached $24.18 billion, up 6.4% year-over-year and
AZZ (AZZ) stock climbed 8.4% after the metal coatings company reported fiscal first-quarter results that topped estimates and raised its FY2027 guidance above Wall Street expectations. The company raised its FY2027 guidance, citing confidence in its strategic execution, op
Nasdaq stuck in range as traders await US CPI The Nasdaq has been rangebound since the last FOMC decision due to Fed tightening risk and overstretched positioning. The market has been under pressure due to heightened tensions in the Middle East, with oil prices ext
HCI Group declares $0.40 quarterly dividend HCI Group has declared a quarterly dividend of $0.40 per share. The dividend is in line with the company's previous dividend payments. The company has now announced a dividend of $0.40 for thirty-one consecutive quarter
Dow Jones futures gain 0.17% to trade around 52,710 during European trading hours on Thursday. Meanwhile, S&P 500 futures and Nasdaq 100 futures advance 0.34% and 0.74%, trading near 7,550 and 29,690, respectively US stock futures rise amid a sharp bounce in tech an
AstraZeneca and Levi shares dropped after clinical trial setbacks and cautious guidance, overshadowing Ampco-Pittsburgh’s strong order growth. AstraZeneca and Ionis Pharmaceuticals shares fell after their Phase 3 CARDIO-TTRansform trial for Wainua in ATTR-CM patients faile
Strategists highlight AI capital expenditures as a key driver for equity performance amid shifting sector dominance. Goldman Sachs strategists identify AI-related capital expenditures as a critical factor rewriting market leadership in equities. The first half of the year
Semiconductor stocks surged despite broader market declines after SK Hynix's $24.5bn ADR offering and China's Nvidia H200 chip approvals. The S&P 500 fell 0.28% amid stagflation concerns, with 78% of the index posting losses. Most industry groups declined, but semiconducto
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.